Archives of Neurology · 1993 · 189 citations · 37 references
Life SciencesNeurobiologyNeuroscienceMolecular NeuroscienceNeurochemistryNeuropharmacologyAge-related Physiologic ChangesAge-related Physiological ChangesDopaminergic PharmacologyDopaminergic SignalingAge-related Brain ChangesBrain RegionsD2-like Dopamine ReceptorsDopamine D2-like ReceptorsDopamine Receptor ImagingDopamine Receptor SubtypesRadiotracer QuantificationTracer Uptake Quantification
Human postmortem and animal experimental results suggest a decline of the cerebral dopaminergic neuronal system with age. In this study, the radiotracer carbon 11-labeled-raclopride and positron emission tomography were applied to determine the effect of age on striatal D2 dopamine receptors in 32 healthy volunteer subjects (age range, 21 to 68 years; median, 31 years). An index of specific 11C-raclopride binding was calculated for putamen, caudate nucleus, and other brain regions in each subject. A significant decrease with age of the index for specific tracer uptake was found in putamen and caudate nucleus. The decrease was steep until 30 years, but slower afterward. After approximately 30 years of age, the decline of specific 11C-raclopride binding in putamen was found to be 0.6% per year. Our results suggest that D2 dopamine receptor binding sites (mainly postsynaptically located) decrease as a consequence of normal aging in parallel with the decline of the presynaptic nigrostriatal dopaminergic neuronal system.
37
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
Julian Fearnley, Andrew J. Lees · Brain · 1991 · 3.5K citations
Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Lars Farde, Håkan Hall, E. Ehrin et al. · Science · 1986 · 842 citations
Medicine, Neuroscience, Pharmacology +16